Pharmaceutical Sourcing and Onshoring Survey 2022 Edition – ResearchAndMarkets.com
September 15, 2022DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Sourcing and Onshoring Survey – 2022 Edition” report has been added to ResearchAndMarkets.com’s offering.
Recent geopolitical events are causing the pharma industry to consider its supply chain more carefully than ever. Highly developed pharma markets rely on foreign suppliers for their drugs, especially China and India. The COVID-19 pandemic, rising raw material and fuel costs, Russia’s war against Ukraine, and other events are prompting industry conversations about drug shortages and supply chain security.
In this report, the publisher assesses the outlook for pharmaceutical supply chains over the next 12 months, to determine to what extent bio/pharmaceutical companies and their service providers are concerned, and whether they plan to “onshore” or “offshore” their manufacturing steps.
Scope
Who should buy this report?
- This 36-page report gives important, expert insight you won’t find in any other source. 17 figures throughout the report illustrate major points and trends. This report is required reading for:
- CMO executives who must have deep understanding of the pharmaceutical supply chain to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
- Overview of supply chain trends and key stakeholders’ attitudes to onshoring and sourcing
- Detailed survey of industry plans to change sourcing strategy
- Analysis by geography, drug molecule type, company type, manufacturing step (active pharmaceutical ingredient, finished dose form, packaging)
Key Topics Covered:
- About the Publisher
- Study Design
- Respondent Mix
- The Onshoring Question
- Other Supply Chain Challenges
- Key Findings
- Appendix
- Contact the Publisher
For more information about this report visit https://www.researchandmarkets.com/r/c86tff
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900